CHD1L over-expression occurs in 46% to 86% of HCC and was correlated with venous infiltration, microsatellite tumor nodule formation, advanced tumor stage, poor disease-free survival and poor overall survival [8]–[12]. Here, CHD1L is linked to hepatocellular carcinoma.